
|Articles|June 1, 2001
- Pharmaceutical Executive-06-01-2001
- Volume 0
- Issue 0
Gathering Light
Author(s)Wayne Koberstein
I intended to write an entirely different column this month. Something like, What the Bush administration has done for you-the pharmaceutical industry-lately. Such as making it harder to do stem-cell research and pursuing an investigation into antigeneric activities. But something else happened. My father died. Now I have no room left in my mind or heart for other matters.
Advertisement
Articles in this issue
over 24 years ago
Industry Under Investigationover 24 years ago
Emotion - The New Brand Integratorover 24 years ago
For Love of the Gameover 24 years ago
Field of Dreamsover 24 years ago
Workshop: Access Optionsover 24 years ago
Emotion - The New Brand Integratorover 24 years ago
Rx-to-OTC: Unwanted Attentionover 24 years ago
Emotion - Biotech Renaissance Manover 24 years ago
Relocation: Coming to Americaover 24 years ago
Stocks: Catching the Market BluesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
2
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
3
Henlius Enters Global Exclusive License Agreement with U-mab Biopharma for Best-in-Class Potential Anti-IL-1RAP mAb
4
Pharmaceutical Executive Daily: Henlius' Exclusive License Agreement with U-Mab Biopharma
5




